127 related articles for article (PubMed ID: 3494452)
1. Enhancement by a synthetic isoprenoid of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
Akiyama S; Shiraishi N; Yoshimura A; Nakagawa M; Yamaguchi T; Shimada T; Kuwano M
Biochem Pharmacol; 1987 Mar; 36(6):861-8. PubMed ID: 3494452
[TBL] [Abstract][Full Text] [Related]
2. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin.
Akiyama S; Gottesman MM; Hanover JA; Fitzgerald DJ; Willingham MC; Pastan I
J Cell Physiol; 1984 Sep; 120(3):271-9. PubMed ID: 6086678
[TBL] [Abstract][Full Text] [Related]
3. Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin.
Kuratomi Y; Akiyama S; Ono M; Shiraishi N; Shimada T; Ohkuma S; Kuwano M
Exp Cell Res; 1986 Feb; 162(2):436-48. PubMed ID: 3484705
[TBL] [Abstract][Full Text] [Related]
4. Potentiation by a biscoclaurine alkaloid, cepharanthine, of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin in HeLa cells.
Shiraishi N; Shimada T; Hagino Y; Kohno K; Kobayashi M; Kuwano M; Akiyama S
Cancer Res; 1988 Mar; 48(5):1307-11. PubMed ID: 3257717
[TBL] [Abstract][Full Text] [Related]
5. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes.
Banker DE; Pastan I; Gottesman MM; Herschman HR
J Cell Physiol; 1989 Apr; 139(1):51-7. PubMed ID: 2496133
[TBL] [Abstract][Full Text] [Related]
6. Genetic characterization of human KB cell lines resistant to epidermal growth factor: Pseudomonas exotoxin conjugates.
Amano F; Pastan I; Gottesman MM
J Cell Physiol; 1988 Jun; 135(3):527-32. PubMed ID: 3260900
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor-dependent growth of human KB cells in a defined medium and altered growth factor requirements of KB mutants resistant to EGF-Pseudomonas exotoxin conjugates.
Amano F; Gottesman MM; Pastan I
J Cell Physiol; 1988 Jun; 135(3):502-8. PubMed ID: 3294236
[TBL] [Abstract][Full Text] [Related]
8. A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain.
Liao CW; Hseu TH; Hwang J
Appl Microbiol Biotechnol; 1995 Jul; 43(3):498-507. PubMed ID: 7632400
[TBL] [Abstract][Full Text] [Related]
9. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas exotoxin A-epidermal growth factor (EGF) mutant chimeric protein as an indicator for identifying amino acid residues important in EGF-receptor interaction.
Shiah HS; Chen TY; Chang CM; Chow JT; Kung HJ; Hwang J
J Biol Chem; 1992 Nov; 267(33):24034-40. PubMed ID: 1429738
[TBL] [Abstract][Full Text] [Related]
11. Mutant KB cells with decreased EGF receptor expression: biochemical characterization.
Hwang J; Richert N; Pastan I; Gottesman MM
J Cell Physiol; 1987 Oct; 133(1):127-34. PubMed ID: 2444605
[TBL] [Abstract][Full Text] [Related]
12. Cytocidal activity of a synthetic isoprenoid, N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, and its potentiation of antitumor drugs against multidrug-resistant and sensitive cells in vitro.
Suzuki H; Tomida A; Nishimura T
Jpn J Cancer Res; 1990 Mar; 81(3):298-303. PubMed ID: 2161816
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.
Tomida A; Tatsuta T; Suzuki H
Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855
[TBL] [Abstract][Full Text] [Related]
14. An EGF-pseudomonas exotoxin A recombinant protein with a deletion in toxin binding domain specifically kills EGF receptor bearing cells.
Lee CH; Lee EC; Tsai ST; Kung HJ; Liu YC; Hwang J
Protein Eng; 1993 Jun; 6(4):433-40. PubMed ID: 8332601
[TBL] [Abstract][Full Text] [Related]
15. EGF ligand fused to truncated Pseudomonas aeruginosa exotoxin A specifically targets and inhibits EGFR‑positive cancer cells.
Hashimi SM; Grant B; Alqurashi N; Alowaidi F; Wei MQ
Oncol Rep; 2018 Nov; 40(5):2690-2697. PubMed ID: 30226622
[TBL] [Abstract][Full Text] [Related]
16. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
Theuer CP; FitzGerald D; Pastan I
J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect in culture of bleomycin-group antibiotics and N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, a synthetic isoprenoid.
Tomida A; Suzuki H
Jpn J Cancer Res; 1990 Nov; 81(11):1184-90. PubMed ID: 1702416
[TBL] [Abstract][Full Text] [Related]
18. [Combined effect of bleomycin and SDB-ethylenediamine, a synthetic isoprenoid, on oral squamous carcinoma cell lines and transplantable nude mouse tumors].
Takahashi Y; Urade M; Kishimoto H; Arimoto T; Yanagisawa T; Yoshioka W
Gan To Kagaku Ryoho; 1995 Jun; 22(7):883-7. PubMed ID: 7540824
[TBL] [Abstract][Full Text] [Related]
19. [The effect of calcium antagonists on intracellular transport of epidermal growth factor and the conjugate of epidermal growth factor with pseudomonas exotoxin].
Akiyama S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):660-8. PubMed ID: 3920969
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.
Nakagawa M; Akiyama S; Yamaguchi T; Shiraishi N; Ogata J; Kuwano M
Cancer Res; 1986 Sep; 46(9):4453-7. PubMed ID: 3731102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
